SelectQuote approves 1-for-20 reverse stock split

SelectQuote's board approved a 1-for-20 reverse stock split to meet NYSE's minimum price requirement. The split, effective November 16, 2026, reduces outstanding shares from 180.2M to 9.0M. CEO Tim Danker expects over $60M in operating cash flow this year, with $1B+ in commissions receivable.

Original reporting
Published Nov 13, 2026, 1:40 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 13, 2026, 1:50 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$SLQT
Neutral
high confidence
Mentioned
$SLQT
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$SLQTNeutralMed
01

Why it matters

The split aims to restore compliance and may improve liquidity, but the fundamental business outlook remains unchanged.

02

Market read

The announcement is a primary corporate action for SLQT, likely causing a short-term price adjustment but limited broader market impact.

03

What to watch

Potential dilution from outstanding warrants and equity awards after the split could offset price gains.

Relevance 7/10Novelty 8/10Timing: effective after market close on Nov 16, trading on split-adjusted basis at open on Nov 17

Background

SelectQuote is a U.S.-listed insurance brokerage whose shares have fallen below NYSE minimum price requirements, prompting the reverse split.

Company-level read

Ticker impact

$SLQTNeutralHigh confidence
Context

SelectQuote's board approved a 1-for-20 reverse stock split to regain NYSE minimum price compliance.

Expected impact

likely modest upside as the market prices in the higher share price and compliance restoration

Evidence & confidence

Reverse splits are typically viewed positively when they address listing requirements; no other material changes are disclosed.

Market effects

Minimal impact on the broader insurance brokerage sector; the split is a company-specific compliance move.

Limited to U.S. investors holding SLQT; no broader regional effect.

Low; the news is not expected to influence global markets.

Counterpoint

Some investors may view the split as a cosmetic fix that does not address underlying business performance, suggesting caution.

Key entities

  • SelectQuote, Inc.

    Issuer of the reverse stock split.

  • Tim Danker

    CEO of SelectQuote who commented on cash flow expectations.

Related articles

$SLQTMed

SelectQuote Inc (SLQT) (Q1 2027) Earnings Call Highlights: Beats EBITDA and Cash Flow

SelectQuote Inc (SLQT) reported Q1 2027 earnings, beating EBITDA and cash flow estimates. President Bob noted stable plan termination and high beneficiary engagement. CFO Ryan Clement highlighted progress toward a $60M operating cash flow target, with potential future cash dividends. CEO Tim Danker mentioned strong front-end production and improved recapture rates. The company is expanding its Olathe facility and investing in technology for other sites.

$SLQTMedAI 8/10

SelectQuote places fewer Medicare policies but earns more on each one

SelectQuote (SLQT) approved 18% fewer Medicare Advantage policies in Q1 2027, with revenue falling to $280M from $329M. However, commission values per policy rose 16% to $890. The company is shrinking its agent force to improve efficiency, and adjusted EBITDA losses narrowed. Healthcare Services revenue fell 16% but adjusted EBITDA rose 56%. SelectQuote maintained its full-year guidance and faces a False Claims Act lawsuit.

$SLQTMed

What SelectQuote (SLQT) Said on Its Q1 Earnings Call

SelectQuote (SLQT) reported Q1 earnings, with Senior revenue declining to $51M from $59M, but adjusted EBITDA loss narrowing. Healthcare Services revenue fell to $186M, while adjusted EBITDA rose 56% to $11M. Life Insurance revenue declined to $43M, but adjusted EBITDA increased 31% to $7M. The company plans a reverse stock split and invests in AI and technology. Management noted stability in commissions and potential carrier marketing efforts.

$SLQTMed

SelectQuote (SLQT) Q1 2027 Earnings Call Transcript

SelectQuote (SLQT) reported a Q1 2027 adjusted EBITDA loss of $17M, improved from last year. Revenue was $280M, down 15% YoY. Senior segment lost $12M (improved $9M YoY), while Healthcare Services EBITDA rose 56% YoY to $11M. The company reiterated its fiscal 2027 operating cash flow target of at least $60M, citing strong profitability and cash flow performance.

$SLQTMedAI 8/10

SelectQuote (SLQT) Q1 2027 Earnings Call Transcript

SelectQuote (SLQT) reported Q1 2027 revenue of $280M, down 15% YoY, with an adjusted EBITDA loss of $17M. Senior revenue fell 14% YoY, while Medicare Advantage policies decreased 18%. Healthcare Services revenue dropped 16%, but EBITDA grew 56%. The company maintained full-year guidance and plans a reverse stock split. Management prioritized profitability over volume, leveraging AI and operational efficiencies.

Med

SelectQuote, Inc. Q1 2027 Earnings Call Summary

SelectQuote reported a $15M year-over-year adjusted EBITDA gain in Q1 2027, driven by a focus on profitability over volume. Healthcare Services margins increased 60% through member base optimization. Revenue declines in the Senior segment were planned. Management expects $60M operating cash flow in fiscal 2027 and a path to cash-paying preferred dividends by fiscal 2028. The Inflation Reduction Act impacted revenue but was offset by reimbursements.